** Shares of AI biologics firm Absci Corp ABSI.O rise 30.6% to $4.01 premarket
** Co announces a strategic collaboration with Advanced Micro Devices AMD.O, where the chipmaker will invest $20 mln in co to power AI drug discovery
** The investment is structured as a private investment in public equity or PIPE financing
** The partnership will provide AI solutions and also help reduce infrastructure costs for ABSI
** ABSI will deploy AMD's AI chips to help in drug discovery which "will enable us to further the development of next-generation antibody therapeutics"- ABSI
** Absci previously struck a deal worth up to $247 mln with drugmaker AstraZeneca AZN.L to design an antibody to fight cancer
** Up to last close, ABSI had fallen 8.6% in the past 12 months
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。